AI’s Increasing Role in Clinical Trials at Bayer
AI technologies are transforming clinical trial workflows, aiming to shorten timelines and enhance efficiency in pharmaceutical R&D. Bayer's Patricio La Rosa discusses the practical challenges of integrating AI, including scalability, regulatory hurdles, cybersecurity, and new incentive models for patient data use.